Etiology of lung cancer

Textbook of Lung Cancer: Second Edition

Volumn , Issue , 2008, Pages 1-9

  Haugen, Aage ^a   Mollerup, Steen ^a  

^a NATIONAL INSTITUTE OF OCCUPATIONAL HEALTH   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85178071626     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (58)

1. World Cancer Research Fund, American Institute for Cancer Research. Food, nutrition and the prevention of cancer: a global perspective. Washington, DC: American Institute for Cancer Research, 1997: 37-145.
2. Parkin DM, Pisani P, Lopez AD, Masuyer E. At least one in seven cases of cancer is caused by smoking: global estimates for 1985. Int J Cancer 1994; 59: 494-504.
3. International Agency for Research on Cancer. Tobacco smoke and involuntary smoking. IARC Monogr Eval Carcin Risk Hum 2004; 83.
4. Hoffmann D, Hoffmann I. The changing cigarette, 1950-1995. J Toxicol Environ Health 1997; 50: 307-64.
5. Swauger JE, Steichen TJ, Murphy PA et al. An analysis of the mainstream smoke chemistry of samples of the US cigarette market acquired between 1995 and 2000. Regul Toxicol Pharmacol 2002; 35: 142-56.
6. US Department of Health and Human Services (DHHS). Reducing the health consequences of smoking: 25 years of progress. A report of the surgeon general, Washington DC: US government printing office, 1989.
7. Fowler J, Bates M. The chemical constituents in cigarettes and cigarette smoke. Priorities for harm reduction. Report to the New Zealand Ministry of Health. Epidemiology and Toxicology group, Porirua, ESR, Kenepura Science Centre.
8. Hecht SS. Cigarette smoking and lung cancer: chemical mechanisms and approaches to prevention. Lancet Oncol 2002; 3: 461-9.
9. Phillips DH. Smoking-related DNA and protein adducts in human tissues. Carcinogenesis 2002; 23: 1979-2004.
10. Phillips DH. DNA adducts as markers of exposure and risk. Mutat Res 2005; 577: 284-92.
11. Vineis P, Perera F. DNA adducts as markers of exposure to carcinogens and risk of cancer. Int J Cancer 2000; 88: 325-8.
12. Calvez FL, Mukeria A, Hunt JD et al. TP53 and KRAS mutation load and types in lung cancers in relation to tobacco smoke: distinct patterns in never, former, and current smokers. Cancer Res 2005; 65: 5076-83.
13. Denissenko MF, Pao A, Tang M, Pfeifer GP. Preferential formation of benzo[a]pyrene adducts at lung cancer mutational hotspots in p53. Science 1996; 274: 430-2.
14. Hecht SS, Carmella SG, Foiles PG et al. Tobacco-specific nitrosamine adducts: studies in laboratory animals and humans. Environ Health Perspect 1993; 99: 57-63.
15. Hecth SS. Human urinary carcinogen metabolites: biomarkers for investigating tobacco and cancer. Carcinogenesis 2002; 23: 907-22.
16. Schuller HM. Mechanisms of smoking-related lung and pancreatic adenocarcinoma development. Nat Cancer Rev 2002; 2: 455-63.
17. Costa M. Toxicity and carcinogenicity of Cr (VI) in animal models and humans. Crit Rev Toxicol 1997; 27: 431-42.
18. Waalkes MP. Cadmium carcinogenesis. Mutat Res 2003; 533: 107-20.
19. Oller AR, Costa M, Oberdorster G. Carcinogenicity assessment of selected nickel compounds. Toxicol Appl Pharmacol 1997; 143: 152-66.
20. International Agency for Research on Cancer. Formaldehyde. IARC Monogr Eval Carcin Risk Hum 1982; 4: 131-2.
21. Khater AEM. Polonium-210 budget in cigarettes. J Environ Radioactivity 2004; 71: 33-41.
22. Little JB, Kennedy AR, McCandy RB. Effect of dose rate on the induction of experimental lung cancer in hamsters by alpha radiation. Radiat Res 1985; 103: 293-9.
23. Rahman I. Oxidative stress, chromatin remodelling and gene transcription in inflammation and chronic lung disease. Biochem Mol Biol 2003; 36: 95-109.
24. Coussens LM, Werb Z. Inflammation and cancer. Nature 2002; 420: 860-7.
25. Hunninghake GW, Crystal RG. Cigarette smoking and lung destruction: accumulation of neutrophils in the lungs of cigarette smokers. Am Rev Respir Dis 1990; 128: 833-8.
26. Kasai H. Analysis of a form of oxidative DNA-damage, 8-hydroxy-2-deoxyguanosine, as a marker of cellular oxidative stress during carcinogenesis. Mutat Res 1997; 387: 147-63.
27. Maneckjee R, Minna JD. Opioid and nicotine receptors affect growth regulation of human lung cancer cell lines. Proc Natl Acad Sci USA 1990; 87: 3294-8.
28. Xin M, Deng X. Nicotine inactivation of the propoptotic function of Bax through phosphorylation. J Biol Chem 2005; 280: 10781-9.
29. Dockery DW, Trichopoulos D. Risk of lung cancer from environmental exposures to tobacco smoke. Cancer Causes Control 1997; 8: 333-45.
30. Husgafvel-Pursiainen K, Boffetta P, Kannio A. p53 mutations and exposure to environmental tobacco smoke in a multicenter study on lung cancer. Cancer Res 2000; 60: 2906-11.
31. Vahakangas KH, Bennett WP, Castren K et al. p53 and K-ras mutations in lung cancers from former and never-smoking women. Cancer Res 2001; 61: 4350-6.
32. Boffetta P. Epidemiology of environmental and occupational cancer. Oncogene 2004; 23: 6392-403.
33. Vineis P, Hoek G, Krzyzanowski M et al. Air pollution and risk of lung cancer in a prospective study in Europe. Int J Cancer 2006; 119: 164-74.
34. Nafstad P, Haheim LL, Oftedal B et al. Lung cancer and air pollution: a 27 year follow up of 16209 Norwegian men. Thorax 2003; 58: 1071-6.
35. Phillips PS, Denman AR. Radon: a human carcinogen. Sci Prog 1997; 80: 317-36.
36. International Agency for Research on Cancer. Ionizing radiation, part 2: some internally deposited radionuclides. IARC Monogr Eval Carcin Risk Hum 2001; 78: 137-66.
37. Darby S, Hill D, Auvinen A, Barros-Dios JM et al. Radon in homes and risk of lung cancer: collaborative analysis of individual data from 13 European case-control studies. BMJ 2005; 330: 223.
38. Siemiatycki J, Richardson L, Straif K et al. Listing occupational carcinogens. Environ Health Perspect 2004; 112: 1447-59.
39. Boffetta P, Jourenkova N, Gustafsson P. Cancer risk from occupational exposure to polycyclic aromatic hydrocarbons. Cancer Causes Control 1997; 8: 444-72.
40. Liddell FDK. The interaction of asbestos and smoking in lung cancer. Ann Occup Hyg 2001; 45: 341-56.
41. Steenland K, Mannetje A, Boffetta P et al. Pooled exposure-response analysis and risk assessment for lung cancer in 10 cohorts of silica-exposed workers: an IARC multicentre study. Cancer Causes Control 2001; 12: 773-84.
42. Syrjanen KJ. HPV infections and lung cancer. J Clin Pathol 2002; 55: 885-91.
43. Brouchet L, Valmary S, Dahan M. Detection of oncogenic virus genomes and gene products in lung carcinoma. Br J Cancer 2005; 92: 743-6.
44. Bailey-Wilson JE, Amos CI, Pinney SM et al. A major lung cancer susceptibility locus maps to chromosome 6q23-25. Am J Hum Genet 2004; 75: 460-74.
45. Liu G, Zhou W, Christiani DC. Molecular epidemiology of non-small cell lung cancer. Semin Respir Crit Care Med 2005; 26: 265-72.
46. Wei Q, Cheng L, Hong WK, Spitz MR. Reduced DNA repair capacity in lung cancer patients. Cancer Res 1996; 56: 4103-7.
47. Zienolddiny S, Campa D, Lind H et al. Polymorphisms of DNA repair genes and risk of non-small cell lung cancer. Carcinogenesis 2006; 27: 560-7.
48. Risch HA, Howe GR, Jain M et al. Are female smokers at higher risk for lung cancer than male smokers? A case-control analysis by histologic type. Am J Epidemiol 1993; 138: 281-93.
49. Zang EA, Wynder EL. Differences in lung cancer risk between men and women: examination of the evidence. J Natl Cancer Inst 1996; 88: 183-92.
50. Henschke CI, Miettinen OS. Women's susceptibility to tobacco carcinogens. Lung Cancer 2004; 43: 1-5.
51. Kreuzer M, Boffetta P, Whitley E et al. Gender differences in lung cancer risk by smoking: a multicentre case-control study in Germany and Italy. Br J Cancer 2000; 82: 227-33.
52. Bain C, Feskanich D, Speizer FE et al. Lung cancer rates in men and women with comparable histories of smoking. J Natl Cancer Inst 2004; 96: 826-34.
53. Toyooka S, Tsuda T, Gazdar AF. The TP53 gene, tobacco exposure, and lung cancer. Hum Mutat 2003; 21: 229-39.
54. Mollerup S, Ryberg D, Hewer A et al. Sex differences in lung CYP1A1 expression and DNA adduct levels among lung cancer patients. Cancer Res 1999; 59: 3317-20.
55. Veglia F, Matullo G, Vineis P. Bulky DNA adducts and risk of cancer: a meta-analysis. Cancer Epidemiol Biomarkers Prev 2003; 12: 157-60.
56. Mollerup S, Berge G, Bæra R et al. Sex differences in risk of lung cancer: expression of genes in the PAH bioactivation pathway in relation to smoking and bulky DNA adducts. Int J Cancer 2006; 119: 141-4.
57. Wei Q, Cheng L, Amos CI et al. Repair of tobacco carcinogen-induced DNA adducts and lung cancer risk: a molecular epidemiology study. J Natl Cancer Inst 2000; 92: 1764-72.
58. Shriver SP, Bourdeau HA, Gubish CT et al. Sex-specific expression of gastrin-releasing peptide receptor: relationship to smoking history and risk of lung cancer. J Natl Cancer Inst 2000; 92: 24-33.